Rare diseases
Investigational molecules
Locations
Back to Germany1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis
GermanyStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
GermanyStudy on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)
GermanyStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
GermanyStudy on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome
GermanyStudy on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds
GermanyStudy of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
GermanyStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GermanyStudy of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup
GermanyLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
GermanyStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
GermanyStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on various cancer types, including metastatic prostate cancer, colorectal cancer, and bladder cancer. Novel therapeutic approaches combining immunotherapy with established treatments are being investigated.
Research aims to improve survival rates and treatment effectiveness through targeted therapies and immunological approaches.
Important research in heart disease and blood conditions, including studies on TTR amyloidosis and prevention of thrombotic events. Novel medications are being tested to improve patient outcomes.
Focus on developing innovative treatments for complex cardiovascular conditions and preventing blood clots.
Advanced research into neurological conditions, particularly focusing on Alzheimer's disease and autoimmune dementia. Studies aim to develop new therapeutic approaches and improve diagnostic tools.
Innovative approaches to treating and managing neurodegenerative conditions.
Critical research in HIV prevention and immune system modulation, including studies on transplant medicine and vaccine development for yellow fever.
Focus on preventing infectious diseases and improving transplant outcomes through immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
